[Surgical treatment options in end-stage heart failure]

Grapow, Martin T R; Carrel, Thierry P; Eckstein, Friedrich S (2011). [Surgical treatment options in end-stage heart failure]. Therapeutische Umschau, 68(2), pp. 95-102. Bern: Huber 10.1024/0040-5930/a000126

Full text not available from this repository. (Request a copy)

Despite significant improvements in pharmacological therapy heart failure is still one of the leading causes for death in the Western World. The gold standard treatment of end-stage heart failure remains cardiac transplantation, but there is a great excess of eligible candidates compared with the low number of suitable donor organs. The variety of surgical organ preserving treatment strategies has significantly increased during the last 20 years, intenting either to delay or even to prevent the need for cardiac transplantation. An individually tailored surgical concept should be considered as an alternative in any heart failure patient who has reached the limits of pharmacologic therapy. This article gives an overview about current and potential future therapeutic options in end-stage heart failure.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiovascular Surgery

UniBE Contributor:

Carrel, Thierry

ISSN:

0040-5930

Publisher:

Huber

Language:

German

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:20

Last Modified:

17 Mar 2015 19:27

Publisher DOI:

10.1024/0040-5930/a000126

PubMed ID:

21271540

URI:

https://boris.unibe.ch/id/eprint/6612 (FactScience: 211608)

Actions (login required)

Edit item Edit item
Provide Feedback